NASDAQ$ZJYL

Jin Medical International Lt · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Headline financials

Total Revenue

$10.3M

Previous: $9.47M+8.3%
EPS (adj)

$0.01

Previous: $0.01+44.4%
Capital Expenditures

$11K

Previous: $14.1K-22.0%
Free Cash Flow

$2.73M

Previous: -$65.4K+4278.0%
Net Income

$1.77M

Previous: $1.23M+44.1%
Operating Income

$1.77M

Previous: $1.02M+74.3%
Gross Profit

$3.53M

Previous: $3.13M+12.7%
Cash & Equivalents

$2.4M

Previous: $3.64M-34.1%
Total Assets

$31M

No prior period

Revenue & EPS history

Jin Medical · Revenue · Quarterly

$10.3M

Q2 2023+8.3%vs Q2 2022

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-8.9%

Avg return

Earnings day

-3.1%

Avg return

5 days after

+12.7%

Avg return

30 days after

0%

0 / 8 earnings

Positive

+0.0%

Q3 2026

Best reaction

-19.9%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2022+0.0%+10.4%+6.7%
Q3 2024+0.0%+10.4%+6.7%
Q3 2026+0.0%+10.4%+6.7%
Q2 2024-7.3%-11.1%-2.5%
Q4 2023-3.8%-7.4%-30.1%
Q2 2022-19.9%-12.4%+38.1%
Q4 2022-19.9%-12.4%+38.1%
Q2 2023-19.9%-12.4%+38.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro